Nursing: Pediatric Pharmacology: Acute Lymphoblastic Leukemia
28.95
Online
Elective
Please select your state to enroll in this course
About the Course:
As primary health care professionals, it is imperative that advanced practice nurses (APNs) clearly understand the pathophysiology of acute lymphoblastic leukemia (ALL), its treatment options, and steps taken to reduce the burden of illness.  APNs are challenged to understand the significance of ALL, its recognition, and its management. A thorough understanding of this pathology will greatly contribute to their ability to recognize this disease and treat the patient or refer to an appropriate specialist for care as appropriate.  This course outlines normally functioning blood and lymphatic systems and how divergences from this process can lead to ALL, the most common type of childhood cancer.  The course highlights the great progress made in understanding this disease and how to eradicate it and will provide an overview of the collateral damage that occurs with this disease from its pathology and its treatment.

Learning Outcomes:
Upon completion of this course, the learner will be able to:
  • Discuss properly functioning blood and lymphatic systems.
  • Characterize typical signs and symptoms of acute lymphoblastic leukemia (ALL).
  • Describe the incidence of ALL.
  • Identify two documented risk factors for ALL.
  • Name the organ system that is always disrupted in ALL.
  • Distinguish between the three distinct phases of ALL therapy.
  • State the main objective of induction therapy.
  • Provide a potential advantage to using liposomal vincristine for the treatment of ALL.
  • Discuss the role of asparaginase in the treatment of ALL.
  • Describe the sequence of high-dose methotrexate and leucovorin therapy.
  • Acknowledge two nonphysical complications of ALL.

About the Author:
Bradley Gillespie, PharmD, is trained as a clinical pharmacist and has practiced in an industrial setting for the past 25+ years. His initial role was as a clinical pharmacology and biopharmaceutics reviewer at the U.S. Food and Drug Administration, followed by 20 years of leading early development programs in the pharma/biotech/nutritional industries. In addition to his industrial focus, he remains a registered pharmacist and enjoys mentoring drug development scientists and health professionals, and leading workshops and developing continuing education programs for pharmacy, nursing, and other medical professionals.

How to receive credit:
  • Read the entire course online or in print which requires a 3-hour commitment of time.
  • Depending on your state requirements you will be asked to complete either:
    • An affirmation that you have completed the educational activity.
    • A mandatory test (a passing score of 70 percent is required). Test questions link content to learning objectives as a method to enhance individualized learning and material retention.
  • Provide required personal information and payment information.
  • Complete the mandatory Self-Assessment and Course Evaluation.
  • Print your Certificate of Completion.

Disclosures:

Resolution of Conflict of Interest
In accordance with the ANCC Standards for Commercial Support for continuing education, Elite implemented mechanisms prior to the planning and implementation of the continuing education activity, to identify and resolve conflicts of interest for all individuals in a position to control content of the course activity.

Sponsorship/Commercial Support and Non-Endorsement
It is the policy of Elite not to accept commercial support. Furthermore, commercial interests are prohibited from distributing or providing access to this activity to learners.

Disclaimer
The information provided in this activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition.
©2019: All Rights Reserved. Materials may not be reproduced without the expressed written permission or consent of Elite Professional Education, LLC. The materials presented in this course are meant to provide the consumer with general information on the topics covered. The information provided was prepared by professionals with practical knowledge of the areas covered. It is not meant to provide medical, legal, or professional advice. Elite Professional Education, LLC recommends that you consult a medical, legal, or professional services expert licensed in your state. Elite Professional Education, LLC has made all reasonable efforts to ensure that all content provided in this course is accurate and up to date at the time of printing, but does not represent or warrant that it will apply to your situation nor circumstances and assumes no liability from reliance on these materials. Quotes are collected from customer feedback surveys. The models are intended to be representative and not actual customers.
 
Want Unlimited CE? Become a Member

Pediatric Pharmacology: Acute Lymphoblastic Leukemia - N31426

28.95
About the Course:
As primary health care professionals, it is imperative that advanced practice nurses (APNs) clearly understand the pathophysiology of acute lymphoblastic leukemia (ALL), its treatment options, and steps taken to reduce the burden of illness.  APNs are challenged to understand the significance of ALL, its recognition, and its management. A thorough understanding of this pathology will greatly contribute to their ability to recognize this disease and treat the patient or refer to an appropriate specialist for care as appropriate.  This course outlines normally functioning blood and lymphatic systems and how divergences from this process can lead to ALL, the most common type of childhood cancer.  The course highlights the great progress made in understanding this disease and how to eradicate it and will provide an overview of the collateral damage that occurs with this disease from its pathology and its treatment.

Learning Outcomes:
Upon completion of this course, the learner will be able to:
  • Discuss properly functioning blood and lymphatic systems.
  • Characterize typical signs and symptoms of acute lymphoblastic leukemia (ALL).
  • Describe the incidence of ALL.
  • Identify two documented risk factors for ALL.
  • Name the organ system that is always disrupted in ALL.
  • Distinguish between the three distinct phases of ALL therapy.
  • State the main objective of induction therapy.
  • Provide a potential advantage to using liposomal vincristine for the treatment of ALL.
  • Discuss the role of asparaginase in the treatment of ALL.
  • Describe the sequence of high-dose methotrexate and leucovorin therapy.
  • Acknowledge two nonphysical complications of ALL.

About the Author:
Bradley Gillespie, PharmD, is trained as a clinical pharmacist and has practiced in an industrial setting for the past 25+ years. His initial role was as a clinical pharmacology and biopharmaceutics reviewer at the U.S. Food and Drug Administration, followed by 20 years of leading early development programs in the pharma/biotech/nutritional industries. In addition to his industrial focus, he remains a registered pharmacist and enjoys mentoring drug development scientists and health professionals, and leading workshops and developing continuing education programs for pharmacy, nursing, and other medical professionals.

How to receive credit:
  • Read the entire course online or in print which requires a 3-hour commitment of time.
  • Depending on your state requirements you will be asked to complete either:
    • An affirmation that you have completed the educational activity.
    • A mandatory test (a passing score of 70 percent is required). Test questions link content to learning objectives as a method to enhance individualized learning and material retention.
  • Provide required personal information and payment information.
  • Complete the mandatory Self-Assessment and Course Evaluation.
  • Print your Certificate of Completion.

Disclosures:

Resolution of Conflict of Interest
In accordance with the ANCC Standards for Commercial Support for continuing education, Elite implemented mechanisms prior to the planning and implementation of the continuing education activity, to identify and resolve conflicts of interest for all individuals in a position to control content of the course activity.

Sponsorship/Commercial Support and Non-Endorsement
It is the policy of Elite not to accept commercial support. Furthermore, commercial interests are prohibited from distributing or providing access to this activity to learners.

Disclaimer
The information provided in this activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition.
©2019: All Rights Reserved. Materials may not be reproduced without the expressed written permission or consent of Elite Professional Education, LLC. The materials presented in this course are meant to provide the consumer with general information on the topics covered. The information provided was prepared by professionals with practical knowledge of the areas covered. It is not meant to provide medical, legal, or professional advice. Elite Professional Education, LLC recommends that you consult a medical, legal, or professional services expert licensed in your state. Elite Professional Education, LLC has made all reasonable efforts to ensure that all content provided in this course is accurate and up to date at the time of printing, but does not represent or warrant that it will apply to your situation nor circumstances and assumes no liability from reliance on these materials. Quotes are collected from customer feedback surveys. The models are intended to be representative and not actual customers.